Mesoblast | MSB - 販売収入

株価
2.15
毎日の変更
0.01 0.47%
毎月
0.47%
毎年
17.17%
Q2 予測
2.15




セールス 変化する 日付
Avita Medical AUD 17.61M 805K 2025-12
Clinuvel Pharmaceuticals AUD 36.93M 22.44M 2025-12
Cochlear AUD 1.18B 590.35M 2025-12
CSL USD 8.33B 4.79B 2025-12
Pacific Edge NZD 5.94M 4.95M 2025-12
Paradigm Biopharmaceuticals AUD 284.06K 292.06K 2025-12
PYC Therapeutics AUD 11.04M 2.44M 2025-12
Ramsay Health Care AUD 9.34B 82.2M 2025-12
Sonic Healthcare AUD 5.45B 470M 2025-12
Starpharma Holdings AUD 10.83M 9.12M 2025-12
Telix Pharmaceuticals AUD 413.44M 103.71M 2025-12